Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy
Open Access
- 1 October 2020
- journal article
- research article
- Published by The Korean Society of Anesthesiologists in Korean Journal of Anesthesiology
- Vol. 73 (5) , 434-444
Abstract
Background: Studies investigating the correlation between spinal adenosine A1 receptors and vincristine-induced peripheral neuropathy (VIPN) are limited. This study explored the role of intrathecal N6-(2-phenylisopropyl)-adenosine R-(-)isomer (R-PIA) in the rat model of VIPN. Methods: Vincristine (100 μg/kg) was intraperitoneally administered for 10 days (two 5-day cycles with a 2-day pause) and VIPN was induced in rats. Pain was assessed by evaluating mechanical hyperalgesia, mechanical dynamic allodynia, thermal hyperalgesia, cold allodynia, and mechanical static allodynia. Biochemically, tumor necrosis factor-alpha (TNF-α) level and myeloperoxidase (MPO) activity were measured in the tissue from beneath the sciatic nerve.Results: Vincristine administration resulted in the development of cold allodynia, mechanical hyperalgesia, thermal hyperalgesia, mechanical dynamic allodynia, and mechanical static allodynia. Intrathecally administered R-PIA (1.0 and 3.0 μg/10 μl) reversed vincristine-induced neuropathic pain (cold and mechanical static allodynia). The attenuating effect peaked 15 min after intrathecal administration of R-PIA after which it decreased until 180 min. However, pretreatment with 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 10 μg/10 μl) 15 min before intrathecal R-PIA administration significantly attenuated the antiallodynic effect of R-PIA. This antiallodynic effect of intrathecal R-PIA may be mediated through adenosine A1 receptors in the spinal cord. Intrathecally administered R-PIA also attenuated vincristine-induced increases in TNF-α level and MPO activity. However, pretreatment with intrathecal DPCPX significantly reversed this attenuation.Conclusions: These results suggest that intrathecally administered R-PIA attenuates cold and mechanical static allodynia in a rat model of VIPN, partially due to its anti-inflammatory actions.Keywords
This publication has 39 references indexed in Scilit:
- Exploring the potential effect of Ocimum sanctum in vincristine-induced neuropathic pain in ratsJournal of Brachial Plexus and Peripheral Nerve Injury, 2014
- Adenosine receptor targeting in health and diseaseExpert Opinion on Investigational Drugs, 2011
- Adenosine Triphosphate–Sensitive Potassium Channel Blockers Attenuate the Antiallodynic Effect of R-PIA in Neuropathic RatsAnesthesia & Analgesia, 2011
- Pain-relieving prospects for adenosine receptors and ectonucleotidasesTrends in Molecular Medicine, 2011
- Ameliorative potential of rosiglitazone in tibial and sural nerve transection-induced painful neuropathy in ratsPharmacological Research, 2009
- The Interaction of Gabapentin and N6-(2-phenylisopropyl)-adenosine R-(-)isomer (R-PIA) on Mechanical Allodynia in Rats with a Spinal Nerve LigationJournal of Korean Medical Science, 2008
- Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in ratsBritish Journal of Pharmacology, 2007
- Evidence for direct axonal toxicity in vincristine neuropathyJournal of the Peripheral Nervous System, 2006
- Mechanical hyperalgesias in neuropathic pain patients: Dynamic and static subtypesAnnals of Neurology, 1993
- Effect of two different routes of administration of R-PIA on glutamate release during ischemiaNeuroscience Letters, 1992